• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种基于知识的方法在药物发现组合或药物化学文库设计中的应用。1. 已知药物数据库的定性和定量表征。

A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases.

作者信息

Ghose A K, Viswanadhan V N, Wendoloski J J

机构信息

Amgen Inc., Thousand Oaks, California 91320, USA.

出版信息

J Comb Chem. 1999 Jan;1(1):55-68. doi: 10.1021/cc9800071.

DOI:10.1021/cc9800071
PMID:10746014
Abstract

The discovery of various protein/receptor targets from genomic research is expanding rapidly. Along with the automation of organic synthesis and biochemical screening, this is bringing a major change in the whole field of drug discovery research. In the traditional drug discovery process, the industry tests compounds in the thousands. With automated synthesis, the number of compounds to be tested could be in the millions. This two-dimensional expansion will lead to a major demand for resources, unless the chemical libraries are made wisely. The objective of this work is to provide both quantitative and qualitative characterization of known drugs which will help to generate "drug-like" libraries. In this work we analyzed the Comprehensive Medicinal Chemistry (CMC) database and seven different subsets belonging to different classes of drug molecules. These include some central nervous system active drugs and cardiovascular, cancer, inflammation, and infection disease states. A quantitative characterization based on computed physicochemical property profiles such as log P, molar refractivity, molecular weight, and number of atoms as well as a qualitative characterization based on the occurrence of functional groups and important substructures are developed here. For the CMC database, the qualifying range (covering more than 80% of the compounds) of the calculated log P is between -0.4 and 5.6, with an average value of 2.52. For molecular weight, the qualifying range is between 160 and 480, with an average value of 357. For molar refractivity, the qualifying range is between 40 and 130, with an average value of 97. For the total number of atoms, the qualifying range is between 20 and 70, with an average value of 48. Benzene is by far the most abundant substructure in this drug database, slightly more abundant than all the heterocyclic rings combined. Nonaromatic heterocyclic rings are twice as abundant as the aromatic heterocycles. Tertiary aliphatic amines, alcoholic OH and carboxamides are the most abundant functional groups in the drug database. The effective range of physicochemical properties presented here can be used in the design of drug-like combinatorial libraries as well as in developing a more efficient corporate medicinal chemistry library.

摘要

基因组研究中各种蛋白质/受体靶点的发现正在迅速扩展。随着有机合成和生化筛选的自动化,这正在给整个药物研发领域带来重大变革。在传统的药物研发过程中,制药行业要测试数千种化合物。有了自动化合成,待测试的化合物数量可能达到数百万种。这种二维的扩展将导致对资源的巨大需求,除非化学文库的构建明智合理。这项工作的目标是对已知药物进行定量和定性表征,这将有助于生成“类药物”文库。在这项工作中,我们分析了《综合药物化学》(CMC)数据库以及属于不同类别的药物分子的七个不同子集。这些包括一些中枢神经系统活性药物以及心血管、癌症、炎症和感染疾病状态的药物。本文基于计算得到的物理化学性质概况(如log P、摩尔折射率、分子量和原子数)进行了定量表征,并基于官能团和重要子结构的出现情况进行了定性表征。对于CMC数据库而言,计算得到的log P的合格范围(涵盖超过80%的化合物)在 -0.4至5.6之间,平均值为2.52。对于分子量,合格范围在160至480之间,平均值为357。对于摩尔折射率,合格范围在40至130之间,平均值为97。对于原子总数,合格范围在20至70之间,平均值为48。苯是该药物数据库中迄今为止最丰富的子结构,比所有杂环的总和略多。非芳香族杂环比芳香族杂环丰富两倍。叔脂肪胺、醇羟基和羧酰胺是药物数据库中最丰富的官能团。这里呈现的物理化学性质的有效范围可用于设计类药物组合文库以及开发更高效的企业药物化学文库。

相似文献

1
A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases.一种基于知识的方法在药物发现组合或药物化学文库设计中的应用。1. 已知药物数据库的定性和定量表征。
J Comb Chem. 1999 Jan;1(1):55-68. doi: 10.1021/cc9800071.
2
Drug discovery in the kinase inhibitory field using the Nested Chemical Library technology.利用嵌套化学文库技术在激酶抑制领域进行药物发现。
Assay Drug Dev Technol. 2005 Oct;3(5):543-51. doi: 10.1089/adt.2005.3.543.
3
Leadlikeness and structural diversity of synthetic screening libraries.合成筛选库的类先导性和结构多样性。
Mol Divers. 2006 Aug;10(3):377-88. doi: 10.1007/s11030-006-9040-6. Epub 2006 Sep 21.
4
Expanding the medicinally relevant chemical space with compound libraries.利用化合物库拓展具有药用相关性的化学空间。
Drug Discov Today. 2012 Jul;17(13-14):718-26. doi: 10.1016/j.drudis.2012.04.001. Epub 2012 Apr 10.
5
Property distributions: differences between drugs, natural products, and molecules from combinatorial chemistry.性质分布:药物、天然产物与组合化学分子之间的差异
J Chem Inf Comput Sci. 2003 Jan-Feb;43(1):218-27. doi: 10.1021/ci0200467.
6
Chemical substructures in drug discovery.药物发现中的化学亚结构
Drug Discov Today. 2003 Jul 1;8(13):594-602. doi: 10.1016/s1359-6446(03)02740-5.
7
Integrating medicinal chemistry, organic/combinatorial chemistry, and computational chemistry for the discovery of selective estrogen receptor modulators with Forecaster, a novel platform for drug discovery.利用 Forecaster 这一新型药物发现平台,将药物化学、有机/组合化学和计算化学相结合,以发现选择性雌激素受体调节剂。
J Chem Inf Model. 2012 Jan 23;52(1):210-24. doi: 10.1021/ci2004779. Epub 2011 Dec 15.
8
Current parallel chemistry principles and practice: application to the discovery of biologically active molecules.当前的平行化学原理与实践:在生物活性分子发现中的应用
Curr Opin Drug Discov Devel. 2009 Nov;12(6):899-914.
9
Lessons learnt from assembling screening libraries for drug discovery for neglected diseases.从为被忽视疾病药物研发组装筛选文库中吸取的经验教训。
ChemMedChem. 2008 Mar;3(3):435-44. doi: 10.1002/cmdc.200700139.
10
Design of small molecule libraries for NMR screening and other applications in drug discovery.用于核磁共振筛选及药物发现中其他应用的小分子文库设计。
Curr Top Med Chem. 2003;3(1):11-23. doi: 10.2174/1568026033392606.

引用本文的文献

1
Prospects for the structure‒function evolution of SARS-CoV-2 main protease inhibitors.严重急性呼吸综合征冠状病毒2型主要蛋白酶抑制剂的结构-功能演变前景
J Comput Aided Mol Des. 2025 Sep 15;39(1):78. doi: 10.1007/s10822-025-00654-9.
2
MEDT insights into the mechanism and selectivity of the (3 + 2) cycloaddition of ()--methyl--(2-furyl)-nitrone with but-2-ynedioic acid and the bioactivity of the reaction products.MEDT对()-甲基-(2-呋喃基)-硝酮与丁-2-炔二酸的(3 + 2)环加成反应的机理和选择性以及反应产物生物活性的见解。
RSC Adv. 2025 Sep 8;15(39):32271-32283. doi: 10.1039/d5ra04143k. eCollection 2025 Sep 5.
3
Immune checkpoints in immune response to glioma: two sides of the same coin.
胶质瘤免疫反应中的免疫检查点:硬币的两面
Front Immunol. 2025 Aug 15;16:1639521. doi: 10.3389/fimmu.2025.1639521. eCollection 2025.
4
Novel Indole-Based Sulfonylhydrazones as Potential Anti-Breast Cancer Agents: Synthesis, In Vitro Evaluation, ADME, and QSAR Studies.新型吲哚基磺酰腙类化合物作为潜在的抗乳腺癌药物:合成、体外评价、药物代谢动力学及定量构效关系研究
Pharmaceuticals (Basel). 2025 Aug 20;18(8):1231. doi: 10.3390/ph18081231.
5
Unlocking Therapeutic Potential of Novel Thieno-Oxazepine Hybrids as Multi-Target Inhibitors of AChE/BChE and Evaluation Against Alzheimer's Disease: In Vivo, In Vitro, Histopathological, and Docking Studies.新型噻吩并恶唑嗪杂化物作为乙酰胆碱酯酶/丁酰胆碱酯酶多靶点抑制剂的治疗潜力解锁及对阿尔茨海默病的评估:体内、体外、组织病理学和对接研究
Pharmaceuticals (Basel). 2025 Aug 17;18(8):1214. doi: 10.3390/ph18081214.
6
Computational Exploration of Bacterial Compounds Targeting Arginine-Specific Mono-Adp-Ribosyl-Transferase 1 (Art1): A Pathway to Novel Therapeutic Anticancer Strategies.靶向精氨酸特异性单 ADP-核糖基转移酶 1(Art1)的细菌化合物的计算探索:通往新型抗癌治疗策略的途径
Curr Issues Mol Biol. 2025 Aug 8;47(8):634. doi: 10.3390/cimb47080634.
7
Targeting the cyclin D/CDK4 Axis to unlock new therapeutic approaches to enhance cancer treatment.靶向细胞周期蛋白D/细胞周期蛋白依赖性激酶4轴以开启增强癌症治疗的新治疗方法。
PLoS One. 2025 Aug 22;20(8):e0330102. doi: 10.1371/journal.pone.0330102. eCollection 2025.
8
Molecular docking analysis of pyrrole derivatives with the human epidermal growth factor receptor 2: Combating breast cancer.吡咯衍生物与人表皮生长因子受体2的分子对接分析:对抗乳腺癌
Bioinformation. 2025 May 31;21(5):1075-1081. doi: 10.6026/973206300211075. eCollection 2025.
9
An organometallic approach to the synthesis of heteropolycyclic compounds from benzenes.一种从苯合成杂多环化合物的有机金属方法。
Nat Commun. 2025 Aug 13;16(1):7504. doi: 10.1038/s41467-025-62835-2.
10
Penicillium-Derived Inhibitors of Lactate Dehydrogenase (PfLDH): A Computational Approach for Novel Antimalarial Therapy Development.青霉来源的乳酸脱氢酶抑制剂(PfLDH):新型抗疟治疗药物研发的计算方法
Scientifica (Cairo). 2025 Aug 4;2025:8838031. doi: 10.1155/sci5/8838031. eCollection 2025.